CSC
SURF

Caldwell Sutter Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Caldwell Sutter Capital’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-200
Closed -$140 – 869
2023
Q1 		$140 Buy
+200
New +$162 ﹤0.01% 557

Other funds holding SURF

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caldwell Sutter Capital's SURF Position: Q2 2023 in Review

Caldwell Sutter Capital sold out of Surface Oncology, Inc. Common Stock (SURF) in Q2 2023, closing a stake of 200 shares — an estimated $140 sold.

Caldwell Sutter Capital first reported a position in SURF in Q1 2023 and held it in 1 quarter. The position peaked at $140 in Q1 2023. 61 funds tracked by Wall St. Rank hold SURF as of Q2 2023.

  • Caldwell Sutter Capital reported no remaining Surface Oncology, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Caldwell Sutter Capital sold 200 Surface Oncology, Inc. Common Stock shares in Q2 2023, an estimated $140.
  • Caldwell Sutter Capital first reported a position in Surface Oncology, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Caldwell Sutter Capital's Surface Oncology, Inc. Common Stock position peaked at $140 in Q1 2023.
  • 61 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q2 2023.

Based on Caldwell Sutter Capital's 13F filing for Q2 2023, filed 19 Jul 2023.